Loading...

PMVP PMV PHARMACEUTICALS INC Other Situations 8-K Filing

PMV

PMVP

PMV PHARMACEUTICALS INC

(PMVP)

2025 8-K

Financial Results Report

Financial Results Announced

Interim Data Announcement

Earnings Releases

Financial Statements

Financial Results

Q3 Financial Results

Lease Termination and Finan...

Annual Meeting of Stockholders

Earnings Report

Financial Results Announcement

Restructuring Plan

Management Changes

Earnings Reports

Phase 1 Trial Results Annou...

Earnings Reports

Annual Meeting of Stockholders

Earnings Report

Bylaws Amendment

Financial Results Announcement

External Links:

On September 10, 2025, PMV Pharmaceuticals, Inc. announced interim data from its PYNNACLE Phase 2 trial of rezatapopt monotherapy targeting TP53 Y220C mutations in solid tumors and held a webinar to discuss the findings.

AI Assistant

PMV PHARMACEUTICALS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.